Search for: "In Re Mdl"
Results 221 - 240
of 1,536
Sort by Relevance
|
Sort by Date
29 Mar 2018, 7:50 am
Caldwell, Eastern District of Kentucky) MDL No. 2814 – In Re: Ford Motor Co. [read post]
8 Mar 2018, 7:06 am
This order established MDL No. 2816, known as In Re: Sorin 3T Heater-Cooler System Products Liability Litigation (No. [read post]
7 Mar 2018, 8:09 am
They're not going to -- none of them are -- none of those are going to solve what we've got. [read post]
2 Mar 2018, 11:26 am
They’re pretty standard fare on mid-afternoon and late-night television. [read post]
1 Mar 2018, 2:35 pm
The settlement would cover those remaining cases in the In re Testosterone Replacement Therapy Products Liability Litigation action. [read post]
1 Mar 2018, 2:35 pm
The settlement would cover those remaining cases in the In re Testosterone Replacement Therapy Products Liability Litigation action. [read post]
28 Feb 2018, 2:46 pm
In fairness, that’s a pretty common problem: Many people have no idea they’re surrounded by it every day, especially in older buildings. [read post]
21 Feb 2018, 1:40 pm
IN RE: Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation MDL-2809 Number of lawsuits pending: 84 Diabetes drugs in this MDL case: Onglyza (saxagliptin) Kombiglyze XR (saxagliptin and metformin) Primary side effect for these cases: Heart Failure Get more information about these drug injury cases and/or free case evaluation. [read post]
12 Feb 2018, 12:05 pm
This Diabetes Drugs Litigation Involves Heart Failure, Myocardial Infarction, And Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In February 2018 the United States Judicial Panel on Multidistrict Litigation (JPML) established MDL No. 2809, IN RE: ONGLYZA (SAXAGLIPTIN) AND KOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN) PRODUCTS LIABILITY LITIGATION. [read post]
1 Feb 2018, 2:12 pm
., In re Silica Products Liab. [read post]
31 Jan 2018, 7:52 am
In re Hyundai and Kia Fuel Economy Litig., No. 15-56014, 2018 WL 505343 (9th Cir. [read post]
25 Jan 2018, 7:47 pm
The Ninth Circuit’s decision this week vacating a class action settlement in In re Hyundai and Kia Fuel Economy Litig., No. 15-65014 (9th Cir. [read post]
19 Jan 2018, 12:47 pm
However, this work will need to be repurposed, imported, and re-reviewed into a full-featured system as the case goes forward. [read post]
4 Jan 2018, 10:59 am
We’ll probably see patent litigators boning up on multidistrict litigation (MDL) procedures. [read post]
27 Dec 2017, 2:33 pm
Litig., No. 14 C 1748, MDL No. 2545, 2017 WL 1833173 (N.D. [read post]
20 Dec 2017, 10:37 am
In re Bair Hugger Forced Air Warming, MDL No. 15-2666, 2017 WL 6397721 (D. [read post]
19 Dec 2017, 6:09 am
Eli Lilly & Co. expanded it to the context of multi-district (MDL) litigation. [read post]
12 Dec 2017, 1:31 pm
D.C. 1999). 3 See In re Breast Implant Cases, 942 F. [read post]
11 Dec 2017, 3:00 am
The plaintiffs brought a putative class action in Illinois state court for one count of legal malpractice against numerous defendants stemming from actions involving the multidistrict litigation, In re Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL 2100, No. 3:09-md-02100-DRH-CJP (“MDL” or “Yaz MDL”). [read post]
30 Nov 2017, 8:59 pm
III) MDL No. 2802 – In re: Epipen (Epinephrine Injection, USP) Employee Retirement Income Security Act (ERISA) Litigation MDL No. 2804 – In re: National Prescription Opiate Litigation MDL No. 2806 – In re: McGregor-Mayweather Boxing Match Pay-Per-View Litigation MDL No. 2807 – In re: Sonic Corp. [read post]
